Tazorac
NDC Package 0023-9155-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Tazorac is tazarotene is used to treat psoriasis or acne. Marketed by Allergan, Inc., this product is identified by NDC 0023-9155 and is authorized under FDA application NDA021184.

Identification & Billing

NDC Package Code
0023-9155-30
Package Description
1 TUBE in 1 CARTON / 30 g in 1 TUBE
Product Code
0023-9155
11-Digit Billing Format
00023915530
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
30 GM

Clinical Specifications

Proprietary Name
Tazorac
Dosage Form
-
Usage Information
Tazarotene is used to treat psoriasis or acne. It is a retinoid product related to Vitamin A. It works by affecting the growth of skin cells. The foam and lotion forms of this medication are only approved for use on acne.

Regulatory & Marketing

Labeler Name
Allergan, Inc.
FDA Application #
NDA021184
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
11-15-2000
End Marketing Date
03-10-2020
Listing Expiration
03-10-2020
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0023-9155). Click a package code to view its specific billing and regulatory data.

0023-9155-15
1 TUBE in 1 CARTON / 3.5 g in 1 TUBE
0023-9155-60
1 TUBE in 1 CARTON / 60 g in 1 TUBE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0023-9155-30 identifies a specific commercial package of 1 tube in 1 carton / 30 g in 1 tube of Tazorac, labeled by Allergan, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Allergan, Inc. on November 15, 2000. The current certification is valid through March 10, 2020.

What are the primary indications for this medication?

Tazarotene is used to treat psoriasis or acne. It is a retinoid product related to Vitamin A. It works by affecting the growth of skin cells. The foam and lotion forms of this medication are only approved for use on acne.

How is this Allergan, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00023915530. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0023-9155-30
11-Digit CMS (5-4-2)
00023-9155-30

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.